Adjunctive Pimavanserin in Patients with Major Depressive Disorder: Combined Results from Two Randomized, Double-Blind, Placebo-Controlled Phase 3 Studies

20256 citationsJournal Articlegreen Open Access

Authors

Adjunctive pimavanserin did not significantly improve depressive symptoms, although pimavanserin was well tolerated.

Good health and well-being

Published in: Psychopharmacology Bulletin

Volume 52, Issue 4, pp. 8-30

Field-Weighted Citation Impact: 1.83